Literature DB >> 17404260

Spontaneous autoreactive memory B cell formation driven by a high frequency of autoreactive CD4+ T cells.

Heath M Guay1, Joseph Larkin, Cristina Cozzo Picca, Laura Panarey, Andrew J Caton.   

Abstract

Although somatically mutated autoantibodies are characteristic of many autoimmune diseases, the processes that can lead to their development remain poorly understood. We have examined the formation of autoreactive memory B cells in PevHA mice, which express the influenza virus PR8 hemagglutinin (HA) as a transgenic membrane bound neo-self-Ag. Using a virus immunization strategy, we show that PR8 HA-specific memory B cell formation can occur in PevHA mice, even though a major subset of PR8 HA-specific B cells is negatively selected from the primary repertoire. Moreover, PR8 HA-specific memory B cells develop spontaneously in TS1 x PevHA mice, which coexpress a transgenic PR8 HA-specific TCR and contain a high frequency of HA-specific CD4(+) T cells. Notably, autoreactive memory B cell formation occurred in TS1 x PevHA mice even though approximately half of the HA-specific CD4(+) T cells were CD25(+)Foxp3(+) cells that could significantly attenuate, but did not completely abolish HA-specific autoantibody production in an adoptive transfer setting. The findings provide evidence that a high frequency of autoreactive CD4(+) T cells can be sufficient to promote autoreactive memory B cell formation in the absence of signals provided by overt immunization or infection and despite the presence of abundant autoantigen-specific CD4(+)CD25(+)Foxp3(+) regulatory T cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404260     DOI: 10.4049/jimmunol.178.8.4793

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  T regulatory cells participate in the control of germinal centre reactions.

Authors:  Carla-Maria Alexander; Lorraine T Tygrett; Alexander W Boyden; Kristy L Wolniak; Kevin L Legge; Thomas J Waldschmidt
Journal:  Immunology       Date:  2011-06-03       Impact factor: 7.397

2.  Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo.

Authors:  Janine Gotot; Catherine Gottschalk; Sonny Leopold; Percy A Knolle; Hideo Yagita; Christian Kurts; Isis Ludwig-Portugall
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

3.  Autoantibody production in lpr/lpr gld/gld mice reflects accumulation of CD4+ effector cells that are resistant to regulatory T cell activity.

Authors:  Brian D Hondowicz; Michele L Fields; Simone A Nish; Joseph Larkin; Andrew J Caton; Jan Erikson
Journal:  J Autoimmun       Date:  2008-06-09       Impact factor: 7.094

4.  Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein.

Authors:  Christopher T Harp; Sara Ireland; Laurie S Davis; Gina Remington; Bonnie Cassidy; Petra D Cravens; Olaf Stuve; Amy E Lovett-Racke; Todd N Eagar; Benjamin M Greenberg; Michael K Racke; Lindsay G Cowell; Nitin J Karandikar; Elliot M Frohman; Nancy L Monson
Journal:  Eur J Immunol       Date:  2010-10       Impact factor: 5.532

5.  Increased number and function of FoxP3 regulatory T cells during experimental arthritis.

Authors:  Kristen Monte; Christina Wilson; Fei F Shih
Journal:  Arthritis Rheum       Date:  2008-12

6.  Regulation of interferon gamma signaling by suppressors of cytokine signaling and regulatory T cells.

Authors:  Joseph Larkin; Chulbul M Ahmed; Tenisha D Wilson; Howard M Johnson
Journal:  Front Immunol       Date:  2013-12-18       Impact factor: 7.561

7.  Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells.

Authors:  Bernadette Pöllinger; Gurumoorthy Krishnamoorthy; Kerstin Berer; Hans Lassmann; Michael R Bösl; Robert Dunn; Helena S Domingues; Andreas Holz; Florian C Kurschus; Hartmut Wekerle
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

Review 8.  The immune factors involved in the pathogenesis, diagnosis, and treatment of Sjogren's syndrome.

Authors:  Yi-fan Huang; Qian Cheng; Chun-miao Jiang; Shu An; Lan Xiao; Yong-chao Gou; Wen-jing Yu; Lei Lei; Qian-ming Chen; Yating Wang; Jun Wang
Journal:  Clin Dev Immunol       Date:  2013-07-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.